Publications

• FIP Call to Action: Mobilising pharmacists across our communities to mitigate the impact of air pollution on health
  
• The Global Threat of Air Pollution and Its Impact on Patient Care: Supporting Pharmacy Practice and Workforce Development
  
• FIP Statement of Principle: Accelerating vaccine equity for pharmacy teams on the front line
  
• Pharmacy based pandemic vaccination programme: regulatory self-assessment tool
  
• FIP Holding Statement on in-pharmacy COVID-19 testing
  
• Intervention on provisional agenda item 14.1 COVID-19 response (WHO148th executive board)
  
• Community pharmacists have a crucial role to play in responsible over-the-counter pain management
  
• Intervention on provisional agenda item 14.1 COVID-19 response (WHO 148th executive board)
  
• Joint statement on substandard and falsified medical products (74th WHA)
  
• Joint statement on public health emergencies and mental health preparedness for and response to the COVID-19 pandemic
  
• FIP vaccination handbook for pharmacists: Procedures, safety aspects, common risk points and frequent questions
  
• Off-label drug use written into Chinese medical law for the first time
  
• Community pharmacy is critical to recovery following the COVID-19 pandemic
  
• Medicines reconciliation: A toolkit for pharmacists
  
• Community Pharmacy Global Report 2021 (Available for FIP members only)
  
• Community pharmacy at a glance 2021
  
• Mitigating the impact of air pollution on health: The role of community pharmacists
  
• The FIP Development Goals
  
• COVID-19: Evaluation of diagnostic testing methods and devices
  
• Addendum to FIP COVID-19 Guidance (November 2020)
  
• Holding Statement on interferon beta and vaccination for COVID-19
  
• FIP COVID-19 guidance (Part 2): Guidelines for pharmacists and the pharmacy workforce
  
• FIP COVID-19 guidance (Part 1): Clinical information and treatment guidelines
  
• FIP COVID-19 Summary 2: Pharmacy operations and facilities
  
• FIP COVID-19 Summary 3: Community pharmacy procedures
  
• FIP COVID-19 Summary 4: Community pharmacy contingency plans
  
• FIP COVID-19 Summary 6: Cleaning and disinfection management
  
• FIP COVID-19 Summary 7: Treatment guidelines and medicines to be stoked
  
• FIP COVID-19 Summary 8: Use of masks
  
• FIP COVID-19 Summary 9: Notice to community pharmacy and customers
  
• FIP holding statement on the use of masks during COVID-19
  
• FIP holding statement on COVID-19 treatment with hydroxychloroquine/chloroquine (June 2020)
  
• FIP statement of principle: Impact of the COVID-19 pandemic on health equity, and vulnerable patients and populations
  
• Follow-up to the high-level meetings of the United Nations General Assembly on health-related issues. Universal health coverage: moving together to build a healthier world
  
• FIP Statement of Policy on Medicines Shortages
  
• Intervention on provisional agenda item global vaccine action plan
  
• Intervention on provisional agenda item 6. Primary health care
  
• Position statement on the use of ibuprofen and other medicines in COVID-19 pandemic
  
• Primary health care (73rd WHA)
  
• Acceso sostenible y equitativo a las vacunas: Establecimiento de prioridades y fijación de políticas en la región de las Américas
  
• FIP Regional Conference for the European Region Delivering primary health care: Pharmacists taking the next leap forward
  
• Patient safety: Pharmacists' role in "Medication without harm"
  
• Give it a shot: Expanding immunisation coverage through pharmacists
  
• Ankara Commitment to Action on Primary Health Care
  
• Amman Commitment to Action on Primary Health Care
  
• Joint Statement of Policy by FIP and the Global Self-Care Federation on Responsible and Effective Self-Care
  
• The role of pharmacists in non-communicable diseases
  
• FIP's intervention on universal coverage (72nd WHA)
  
• FIP's intervention on tobacco (72nd WHA)
  
• FIP Strategic Plan: 2019 - 2024
  
• Pharmacists in the supply chain: The role of the medicines expert in ensuring quality and availability
  
• Pharmacists' authority in pharmaceutical product selection: Therapeutic interchange and substitution
  
• Addressing the global shortages of, and access to medicines and vaccines (142nd WHO Executive Board)
  
• Addressing the global shortage of, and access to medicines and vaccines
  
• Pandemic influenza preparedness framework for the sharing of influenza viruses and access to vaccines and other benefits
  
• Use of medicines by the elderly: The role of pharmacy in promoting adherence
  
• Is there a "Holy Grail" medicine?
  
• The Good Pharmacy Practice guidelines
  
• "Budesonide-formoterol as reliever inhaler: A pilot programme featuring Canadian community pharmacist implementation of recent asthma guideline updates "
  
• Social prescribing by community pharmacists: A missed opportunity for health systems globally
  
• ARV supply and demand — 10 years of successes and challenges at the Antiretroviral Procurement Working Group
  

Digital Events

• Supporting self-care: Women's health
  
• Understanding vaccine hesitancy and building vaccine confidence through effective conversations
  
• Leveraging pharmacists to minimise the impact of air pollution on health: Policy barriers and drivers
  
• Understanding and managing 21st century headaches in the community
  
• Dynamics shaping the future self-care market
  
• FIP “Setting goals for the decade ahead” | Episode 11 | FIP DG 7: Advancing integrated services
  
• Understanding and managing headaches in the community: Therapeutic approaches and advancements in the African region
  
• Understanding and managing headaches in the community: Therapeutic approaches and advancements in the Western Pacific region
  
• FIP “Setting goals for the decade ahead” | Episode 12 | FIP DG 2: Early career training strategy
  
• Trusted for health- Pharmacy, Medication Adherence & Communication
  
• Trusted for health: Pharmacy and Counterfeit Medicines worldwide- problems and solutions
  
• Optimising opioid use through pharmacists
  
• Health illiteracy and vaccine misinformation as determinants for equity: developing policies to establish access to quality information in an equitable way
  
• The pharmacist in the prevention and management of vector-borne diseases: a perspective from the Southeast Asian region
  
• Community pharmacy roles, services and tools to minimise impact of air pollution on health
  
• Selfcare in the digital age
  
• Vaccinations and the genders: Examining inequities in gender access and handling of vaccinations globally to inform pharmacy policy
  
• FIP “Setting goals for the decade ahead” | Episode 10 | FIP DG 4: Advanced and specialist development
  
• Pharmacists’ experiences in crises in Lebanon: The Lebanese financial crisis, COVID-19 pandemic, and the Beirut Port blast.
  
• Supporting self-care: Footcare in diabetes management
  
• Developing Effective Pharmacy-led Vaccination Campaigns
  
• Readying the global population for self-care: Health literacy in the 2020s
  
• The role of pharmacists in the prevention and management of vector-borne diseases: a perspective from the Western Pacific region
  
• FIP “Setting goals for the decade ahead” | Episode 9 | FIP DG 6: Leadership development
  
• Looking ahead: Post-pandemic recovery and restoration of services
  
• Equity, access & sustainability through life’s ages and stages: Enabling a life course-approach to vaccination
  
• FIP “Setting goals for the decade ahead” | Episode 8 | FIP DG 15: People-centred care
  
• Pharmacists in long-term care facilities: Before, during and after the pandemic
  
• Supporting self-care: musculoskeletal pain and chronicity
  
• Joining forces across health professionals towards improved vaccination coverage
  
• Medication adherence workshop
  
• FIP “Setting goals for the decade ahead” | Episode 7 | FIP DG 9: Continuing professional development strategies
  
• The role of pharmacists in the prevention and management of vector-borne diseases: a perspective from the Eastern Mediterranean region
  
• Introducing the FIP ‘Transforming Vaccination Globally, Regional and Nationally’ 2021: Accelerating equity, access and sustainability through policy development and implementation
  
• Delivering person-centred support for self-care: current and future pharmacy practice
  
• Outdoor and indoor air pollution: short- and long-term impacts on health
  
• FIP “Setting goals for the decade ahead” | Episode 6 | FIP DG 21: Sustainability in pharmacy
  
• Obesity and weight management: Pharmacist-led services and approaches
  
• Drugs to tackle a pandemic – something old and something new
  
• Appropriate management in the choice of medicines for self-care
  
• Nutritional approaches to the prevention and management of non-communicable diseases: Roles for pharmacists
  
• FIP “Setting goals for the decade ahead” | Episode 5 | FIP DG 1: Academic capacity
  
• The role of the pharmacist in the prevention and management of vector-borne diseases: African region
  
• Shaping the future of self-care: healthcare needs & challenges
  
• FIP “Setting goals for the decade ahead” | Episode 4 | FIP DG 20: Digital health
  
• FIP “Setting goals for the decade ahead” | Episode 3 | FIP DG 16: Communicable diseases
  
• El farmacéutico en la prevención y manejo de las enfermedades transmisibles por vectores: una perspectiva de la región de las Américas
  
• Medicines reconciliation: an essential pharmacist-led service to ensuring patient safety
  
• Reducing medication harm through medicines use reviews: pharmacists at the frontline
  
• FIP “Setting goals for the decade ahead” | Episode 2 | FIP DG 18: Access to medicines, devices & services
  
• FIP “Setting goals for the decade ahead” | Episode 1 | FIP DG 10: Equity & equality
  
• Generic Drug Global Landscape - An FDA Perspective
  
• FIP Global Virtual Summit: Committing to action to transform vaccination in pharmacy
  
• From regional to global: Common priorities for action to transform vaccination
  
• Necesidades e impulsores regionales de la transformación de la vacunación: Américas
  
• Regional needs and drivers for transforming vaccination: Africa
  
• Regional needs and drivers for transforming vaccination: Western Pacific
  
• Regional needs and drivers for transforming vaccination: Eastern Mediterranean
  
• Regional needs and drivers for transforming vaccination: South East Asia
  
• Regional needs and drivers for transforming vaccination: Europe
  
• Setting transformative goals for vaccination globally
  
• Self-care: managing mild COVID-19 symptoms, dispelling the myths
  
• COVID-19 Guidance on Evaluation of Diagnostic Testing & Methods
  
• Pharmacist vaccinators and patient safety: FIP DG 19 Patient Safety
  
• The Role of Pharmacist Vaccinators in improving access to and equity in healthcare outcomes: FIP DG 10 Equity & equality and FIP DG18 Access to Medicines & Services
  
• Covid-19: toma de decisiones en ausencia de evidencia científica. Farmacovigilancia y tecnovigilancia como herramientas para evaluación de riesgo
  
• Pharmacist vaccinators and antimicrobial stewardship: FIP DG 17 Antimicrobial Stewardship
  
• Pharmacist vaccinators and communicable disease management: FIP DG 16 Communicable Diseases
  
• Removing policy barriers to pharmacist vaccinations: FIP DG 13 Policy Development
  
• Empowering pharmacists to deliver vaccination at the health-system level: FIP DG 7 Advancing Integrated Services
  
• COVID-19 Complex Case Presentations
  
• Vaccination from specialist practice to every day practice: FIP DG 4 Advanced & Specialist Development
  
• Reviewing the FIP Transforming Vaccination Programme: Enabling and supporting our profession
  
• Enabling our workforce: Supporting ongoing competence
  
• Transforming our workforce: Evolving the pharmacist's qualification
  
• Medicines use and quality
  
• Avances en el desarrollo de vacunas contra COVID-19 e importancia de la vacunación en tiempos de pandemia.
  
• Medicines shortages mitigation and waste optimization
  
• Addressing barriers to uptake: Adherence, misinformation & anti-Science
  
• Enabling practice: Empowering pharmacists & removing barriers
  
• Introducing the FIP 'Transforming Vaccination Globally & Regionally' series Programme… needs, action and outcomes
  
• Launch of the FIP AMR Commission
  
• Transforming Global Pharmacy: Launch of the FIP Development Goals
  
• FIP AMR African Regional Workshop
  
• FIP AMR European Regional Workshop
  
• FIP AMR Americas Regional Workshop
  
• FIP AMR South East Asian Regional Workshop
  
• FIP AMR Eastern Mediterranean Regional Workshop
  
• FIP AMR Western Pacific Regional Workshop
  
• Driving AMR action in a new decade
  
• Pharmacy Practice Research priorities during the COVID-19 pandemic
  
• Efectos del COVID-19 en la salud de los profesionales sanitarios y estrategias futuras de prevención
  
• Evidence-based practice during the COVID-19 pandemic
  
• The Rise of Substandard & Falsified Medical Products during the COVID-19 (Part2)
  
• Medicine supply disruptions and shortages during the pandemic
  
• Key considerations for developing COVID-19 treatments: learning from the past and planning for the future
  
• #AfricaTogether Pharmacy against COVID-19
  
• COVID-19 for hospital pharmacists and health-systems: The medication use process
  
• Good pharmacy practice during the COVID-19 pandemic
  
• The rise of substandard & falsified medical products during the COVID-19 pandemic
  
• World pharmacists’ COVID-19 online meeting
  
• Targeted medication safety best practices for hospitals
  
• What you need to know about the FIP Pharmaceutical Workforce Development Goals
  
• Co-administration of flu and COVID vaccines: Improving convenience and vaccination coverage
  
• Therapeutic advances against COVID-19
  
• Combatting Malaria: New horizon of vaccines and drug discovery by young pharmaceutical scientists
  

FIP Programmes

• Non-communicable diseases (NCDs): Work in progress for the FIP NCDs website.
  
• Responsible use of medicines: FIP publications and digital events on responsible use of medicines are providing an overview of FIP’s programme areas.
  
• Patient safety: https://www.fip.org/patient-safety
  
• Prevention: Work in progress for the FIP Prevention website.
  
• COVID-19: https://www.fip.org/coronavirus
  
• Self-care: Work in progress for the FIP FIP Prevention website.